APA (7th ed.) Citation

A, V., AL, W., H, W., TPH, M., JS, R., JL, E., . . . RT, C. (2021). The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platform. Vaccine, 39(22), 3067. https://doi.org/10.1016/j.vaccine.2020.08.050

Chicago Style (17th ed.) Citation

A, Volkmann, et al. "The Brighton Collaboration Standardized Template for Collection of Key Information for Risk/benefit Assessment of a Modified Vaccinia Ankara (MVA) Vaccine Platform." Vaccine 39, no. 22 (2021): 3067. https://doi.org/10.1016/j.vaccine.2020.08.050.

MLA (9th ed.) Citation

A, Volkmann, et al. "The Brighton Collaboration Standardized Template for Collection of Key Information for Risk/benefit Assessment of a Modified Vaccinia Ankara (MVA) Vaccine Platform." Vaccine, vol. 39, no. 22, 2021, p. 3067, https://doi.org/10.1016/j.vaccine.2020.08.050.